GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML ; day:19 ; month:4 ; year:2018 ; pages:1-6
Leukemia ; (19.4.2018), 1-6
- Urheber
-
Al Seraihi, Ahad F.
- Beteiligte Personen und Organisationen
-
Rio-Machin, Ana
Tawana, Kiran
Bödör, Csaba
Wang, Jun
Nagano, Ai
Heward, James A.
Iqbal, Sameena
Best, Steven
Lea, Nicholas
McLornan, Donal
Kozyra, Emilia J.
Wlodarski, Marcin W.
Niemeyer, Charlotte
Scott, Hamish
Hahn, Chris
Ellison, Alicia
Tummala, Hemanth
Cardoso, Shirleny Romualdo
Vulliamy, Tom
Dokal, Inderjeet
Butler, Tom
Smith, Matthew
Cavenagh, Jamie
Fitzgibbon, Jude
SpringerLink (Online service)
- DOI
-
10.1038/s41375-018-0134-9
- URN
-
urn:nbn:de:101:1-2018071517194607672973
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Al Seraihi, Ahad F.
- Rio-Machin, Ana
- Tawana, Kiran
- Bödör, Csaba
- Wang, Jun
- Nagano, Ai
- Heward, James A.
- Iqbal, Sameena
- Best, Steven
- Lea, Nicholas
- McLornan, Donal
- Kozyra, Emilia J.
- Wlodarski, Marcin W.
- Niemeyer, Charlotte
- Scott, Hamish
- Hahn, Chris
- Ellison, Alicia
- Tummala, Hemanth
- Cardoso, Shirleny Romualdo
- Vulliamy, Tom
- Dokal, Inderjeet
- Butler, Tom
- Smith, Matthew
- Cavenagh, Jamie
- Fitzgibbon, Jude
- SpringerLink (Online service)
Ähnliche Objekte (12)
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
Current treatment of juvenile myelomonocytic leukemia
Transient apoptosis inhibition by Bcl-xL overexpression during hematopoietic stem cell transplantation
Practical considerations for diagnosis and management of patients and carriers
Pädiatrische Hämatologie und Onkologie
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review
Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
GFI136N as a therapeutic and prognostic marker for myelodysplastic syndrome
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma
Case report: Lomustine overdose in a 15-year-old, healthy adolescent—a prescription failure
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
Current treatment of juvenile myelomonocytic leukemia
Transient apoptosis inhibition by Bcl-xL overexpression during hematopoietic stem cell transplantation
Practical considerations for diagnosis and management of patients and carriers
Pädiatrische Hämatologie und Onkologie
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review
Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
GFI136N as a therapeutic and prognostic marker for myelodysplastic syndrome
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma
Case report: Lomustine overdose in a 15-year-old, healthy adolescent—a prescription failure
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
Current treatment of juvenile myelomonocytic leukemia
Transient apoptosis inhibition by Bcl-xL overexpression during hematopoietic stem cell transplantation
Practical considerations for diagnosis and management of patients and carriers
Pädiatrische Hämatologie und Onkologie
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review
Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
GFI136N as a therapeutic and prognostic marker for myelodysplastic syndrome
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma